CRP and tuberculosis: Several studies exploring changes in serum CRP levels throughout the anti-TB treatment course have confirmed a substantial decline in the levels of this biomarker during the first weeks of treatment, reflecting the attenuation of the inflammation related to Mycobacterium tuberculosis (Mtb) clearance from the lungs and extrapulmonary sites [9,14,17,18,19,20].